D

Dx & Vx Co Ltd
KOSDAQ:180400

Watchlist Manager
Dx & Vx Co Ltd
KOSDAQ:180400
Watchlist
Price: 7 740 KRW -4.33% Market Closed
Market Cap: 154.5B KRW

Dx & Vx Co Ltd
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Dx & Vx Co Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
D
Dx & Vx Co Ltd
KOSDAQ:180400
Revenue
â‚©29B
CAGR 3-Years
22%
CAGR 5-Years
35%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Revenue
â‚©3.9T
CAGR 3-Years
18%
CAGR 5-Years
18%
CAGR 10-Years
22%
P
PharmaResearch Co Ltd
KOSDAQ:214450
Revenue
â‚©449.8B
CAGR 3-Years
37%
CAGR 5-Years
37%
CAGR 10-Years
30%
Alteogen Inc
KOSDAQ:196170
Revenue
â‚©158.1B
CAGR 3-Years
64%
CAGR 5-Years
29%
CAGR 10-Years
39%
A
ABL Bio Inc
KOSDAQ:298380
Revenue
â‚©94.9B
CAGR 3-Years
109%
CAGR 5-Years
96%
CAGR 10-Years
N/A
D
DND PharmaTech Inc
KOSDAQ:347850
Revenue
â‚©11.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Dx & Vx Co Ltd
Glance View

Market Cap
154.5B KRW
Industry
Biotechnology

Dx & Vx Co., Ltd. engages in the development of molecular diagnostic products. The company is headquartered in Seoul, Seoul. The company went IPO on 2014-12-15. The Molecular Diagnosis Business segment is engaged in the manufacture and sale of deoxyribonucleic acid (DNA) chips, polymerase chain reaction (PCR) chips and other products. manufacture and sale of diagnostic reagents used for molecular diagnosis, and various enzymes and experimental reagents used for biological research.

Intrinsic Value
6 120.97 KRW
Overvaluation 21%
Intrinsic Value
Price
D

See Also

What is Dx & Vx Co Ltd's Revenue?
Revenue
29B KRW

Based on the financial report for Jun 30, 2025, Dx & Vx Co Ltd's Revenue amounts to 29B KRW.

What is Dx & Vx Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
35%

Over the last year, the Revenue growth was -35%. The average annual Revenue growth rates for Dx & Vx Co Ltd have been 22% over the past three years , 35% over the past five years .

Back to Top